TRIB (trinitybiotech.com) Return on Sales by Gross Profit

Analyzing the gross profit to revenue ratio on GURU.Markets, we find that 33.00 is the current value of the metric, confirming the profitability of global supplies of diabetes diagnostic equipment for Trinity Biotech plc (TRIB). The business foundation is supported by updated management focused on debt repayment and stringent FDA/CE certifications, which create an insurmountable barrier for competitors in the hospital sector.
Financial and market metric breakdowns for Trinity Biotech PLC (TRIB)

Trinity Biotech plc (TRIB) procures test components from third-party suppliers, making the control of assembly costs a critical efficiency factor. This metric measures the profit share after deducting direct production costs, allowing investors to distinguish temporary reagent price spikes from a systemic decline in profitability by analyzing the current gross margin to determine the asset's fair value.